Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspirin resistance: a new independent predictor of vascular events?

Literature DB >> 12651042

Aspirin resistance: a new independent predictor of vascular events?

John W Eikelboom¹, Graeme J Hankey.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2003 PMID： 12651042 DOI： 10.1016/s0735-1097(02)03013-9

Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors: K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal: Clin Pharmacol Ther Date: 2007-03 Impact factor: 6.875

2. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Authors: Gergely Feher; Katalin Koltai; Elod Papp; Balint Alkonyi; Alexander Solyom; Peter Kenyeres; Gabor Kesmarky; Laszlo Czopf; Kalman Toth
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

Review 3. Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease.

Authors: Amgad N Makaryus
Journal: Clin Cardiol Date: 2006-04 Impact factor: 2.882

Review 4. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.

Authors: Michael Pignone; Craig D Williams
Journal: Nat Rev Endocrinol Date: 2010-09-21 Impact factor: 43.330

5. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.

Authors: Tilo Grosser; Susanne Fries; John A Lawson; Shiv C Kapoor; Gregory R Grant; Garret A FitzGerald
Journal: Circulation Date: 2012-12-04 Impact factor: 29.690

6. Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting.

Authors: S Müller-Schunk; J Linn; N Peters; M Spannagl; M Deisenberg; H Brückmann; T E Mayer
Journal: AJNR Am J Neuroradiol Date: 2008-01-25 Impact factor: 3.825

Aspirin resistance: a new independent predictor of vascular events?

Review 1. The pharmacogenetics research network: from SNP discovery to clinical drug response.

2. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Review 3. Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease.

Review 4. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.

5. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.

6. Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting.

7. Findings of intravascular ultrasound during acute stent thrombosis.

8. Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations.

9. Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses.

10. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.